Inventor
GRAINGER DAVID J
GB38 patents
⚠️ This page may combine multiple inventors who share the name “GRAINGER DAVID J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NEORX CORP
19 patentsUS6410587B1Jun 25, 2002
Compounds and therapies for the prevention of vascular and non-vascular pathologies
NEORX CORP94 citations99
US6117911ASep 12, 2000
Compounds and therapies for the prevention of vascular and non-vascular pathologies
NEORX CORP219 citations99
US5595722AJan 21, 1997
Method for identifying an agent which increases TGF-beta levels
NEORX CORP182 citations99
US5811447ASep 22, 1998
Therapeutic inhibitor of vascular smooth muscle cells
NEORX CORP402 citations98
US5770609AJun 23, 1998
Prevention and treatment of cardiovascular pathologies
NEORX CORP154 citations98
US5599844AFeb 4, 1997
Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
NEORX CORP99 citations98
US7084171B2Aug 1, 2006
Compounds and therapies for the prevention of vascular and non-vascular pathologies
NEORX CORP41 citations96
US5945456AAug 31, 1999
Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
NEORX CORP42 citations96
US5847007ADec 8, 1998
Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
NEORX CORP26 citations96
US5773479AJun 30, 1998
Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
NEORX CORP48 citations96
US5472985ADec 5, 1995
Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
NEORX CORP51 citations96
US6262079B1Jul 17, 2001
Prevention and treatment of cardiovascular pathologies
NEORX CORP42 citations95
US6197789B1Mar 6, 2001
Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
NEORX CORP53 citations95
US5545569AAug 13, 1996
Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
NEORX CORP70 citations94
US6734208B2May 11, 2004
Compounds and therapies for the prevention of vascular and non-vascular pathologies
NEORX CORP19 citations92
US6251920B1Jun 26, 2001
Prevention and treatment of cardiovascular pathologies
NEORX CORP24 citations92
US6395494B1May 28, 2002
Method to determine TGF-β
NEORX CORP20 citations90
US7094550B2Aug 22, 2006
Method to determine TGF-beta
NEORX CORP13 citations82
US6166090ADec 26, 2000
Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
NEORX CORP6 citations73
CAMBRIDGE ENTPR LTD
8 patentsUS8008288B2Aug 30, 2011
Anti-inflammatory A-aminocyclolactam compounds
CAMBRIDGE ENTPR LTD2 citations62
US8008289B2Aug 30, 2011
α-aminocyclolactam ligands for G-protein coupled receptors
CAMBRIDGE ENTPR LTD2 citations62
US7989466B2Aug 2, 2011
Methods to inhibit or augment an inflammatory response
CAMBRIDGE ENTPR LTD4 citations62
US7897620B2Mar 1, 2011
Methods of using anti-inflammatory compounds
CAMBRIDGE ENTPR LTD4 citations62
US7803794B2Sep 28, 2010
Anti-inflammatory agents
CAMBRIDGE ENTPR LTD3 citations62
US7691845B2Apr 6, 2010
Anti-inflammatory agents
CAMBRIDGE ENTPR LTD2 citations62
US7662967B2Feb 16, 2010
Anti-inflammatory compounds and compositions
CAMBRIDGE ENTPR LTD4 citations62
US7700087B2Apr 20, 2010
Compounds and methods to inhibit or augment an inflammatory response
CAMBRIDGE ENTPR LTD3 citations59
GRAINGER DAVID J
6 patentsUS8481558B2Jul 9, 2013
Compounds to inhibit or augment an inflammatory response
GRAINGER DAVID J4 citations54
US8497261B2Jul 30, 2013
3-aminocaprolactam compounds for treating inflammatory disorders
GRAINGER DAVID J0 citations50
US8389279B2Mar 5, 2013
α-aminocyclolactam ligands for G-protein coupled receptors, and methods of using same
GRAINGER DAVID J0 citations50
US8076323B2Dec 13, 2011
Anti-inflammatory agents
GRAINGER DAVID J1 citations50
US8063106B2Nov 22, 2011
ApoE mimetic agents
GRAINGER DAVID J0 citations50
US8618283B2Dec 31, 2013
Ligand libraries for screening GPCRs
GRAINGER DAVID J0 citations40
UNIV CAMBRIDGE TECH
3 patentsUS7238711B1Jul 3, 2007
Compounds and methods to inhibit or augment an inflammatory response
UNIV CAMBRIDGE TECH32 citations92
US6989435B2Jan 24, 2006
Compounds and methods to inhibit or augment an inflammatory response
UNIV CAMBRIDGE TECH24 citations92
US7067117B1Jun 27, 2006
Compounds and methods to inhibit or augment an inflammatory response
UNIV CAMBRIDGE TECH9 citations70